Ultrasound-guided percutaneous injection of triamcinolone acetonide for treating capsular contracture in patients with augmented and reconstructed breast

摘要: To evaluate ultrasound (US)-guided treatment of capsular contracture (CC) in patients with reconstructed/augmented breast. Twenty-five grade IV CC were treated peri-implant US-guided injection triamcinolone acetonide. Before/after treatment, maximum thickness (MCT) was measured by and pain assessed visual analogue score (pain-VAS). Patients relief at 1 month considered early responders (ERs). Another performed without (late responders, LRs). One patient (treated chemo-radiotherapy) experienced severe local reaction after the second injection, requiring surgery. Twenty-four had baseline MCT 1.8 ± 0.3 mm pain-VAS 4.9 ± 0.5, 19 ERs (1.7 ± 0.2 mm) being significantly lower than that 5 LRs (2.1 ± 0.2 mm) (p = 0.030). reduced one (1.1 ± 0.3 mm; 1.5 ± 0.5) 6 months (1.1 ± 0.2 mm; 0.9 ± 0.7, respectively) (p < 0.001). At 1 month, a (1.6 ± 0.1 mm, p = 0.042) but non-significantly changed (4.7 ± 0.2); 5 months later, reached 1.0 ± 0.1 mm, 0.8 ± 0.5 (p < 0.044). Significant correlation between relative variation (1 month/baseline) found. acetonide is effective treating CC.